L'Oréal Leads Investment in Chinese AI Biotech PAM2L
L'Oréal has taken a minority stake in Chinese AI-biomaterials firm PAM2L via its BOLD fund, building on Augmented Colanic Acid, already used in the Age Perfect Collagen Royal Series.
Topic
Topic
L'Oréal has taken a minority stake in Chinese AI-biomaterials firm PAM2L via its BOLD fund, building on Augmented Colanic Acid, already used in the Age Perfect Collagen Royal Series.